USPTO 2015–2025 USPTO PatentsView US Corporation

NociMed, Inc.

USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Nocimed ranks #23,097 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.

#23,097
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.8/100)
25.1
avg claims per patent
-80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23097 · US Corporation #23,097 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,097/49,997
  • PHOTO-FINISH Ningbo Forward Plastic
  • CPC-NARROW A61B · 5 areas
  • INNOV-THIN 31.8/100
  • CLAIMS-DENSE 25.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ningbo Forward Plastic Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nocimed’s 31.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Nocimed

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Nocimed's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Nocimed?

Each dot is one of Nocimed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nocimed’s own 25.1 claims/patent is ABOVE the 8.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nocimed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 0102030 Granted patents (volume) Avg claims / patent Ningbo Forward Plastic Co., Ltd. - 12, 1Ningbo Forward Pl…Ningbo Yousun Imp. and Exp. Co., Ltd - 12, 1Ningbo Yousun Imp…Nippon Tanshi Co., Ltd. - 12, 7.75Nippon TanshiNoCell Technologies, LLC - 12, 19.25NocellNorMedix, Inc. - 12, 21.42NormedixNorell, Inc. - 12, 8.08NorellNorthern Trust Corporation - 12, 20.17Northern TrustNostrum Energy PTE. Ltd. - 12, 23.67Nostrum Energy PTENociMed, Inc. - 12, 25.08Nocimed
Nocimed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nocimed's grants concentrate

NociMed, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2015. By volume, Nocimed sits between Ningbo Forward Plastic Co., Ltd. and Nostrum Energy PTE. Ltd..

Who files at NociMed's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows NociMed holds 12 patents at rank #23,099, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near NociMed

By rank, the assignees closest to #23,099 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NociMed's primary technology class.

Nocimed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2015201620172018201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
NociMed, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 8.3%
2016 3 25.0%
2017 2 16.7%
2018 1 8.3%
2019 3 25.0%
2020 1 8.3%
2021 1 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

NociMed, Inc.'s patent record in context - here's where to go next.

  • NociMed, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #23,097 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare NociMed, Inc. against Ningbo Forward Plastic Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.